PHILADELPHIA, PA / ACCESSWIRE / November 25, 2022 / Kaskela Law LLC announces that it is investigating Xtant Medical Holdings Inc. ("Xtant") (NYSE:XTNT) on behalf of the Company's investors.
Since July 2021, shares of Xtant's common stock have declined in value from a trading price of $2.00 per share to a current trading price of less than $0.70 per share, a cumulative decline of over 65% in value.
The investigation seeks to determine whether Xtant and/or the company's representatives violated the securities laws by issuing false and/or misleading statements and/or failing to disclose material information to Xtant investors, thereby causing investor losses.
Xtant stockholders are encouraged to contact Kaskela Law LLC (Adrienne Bell, Esq.) at (484) 229 - 0750, or by email ([email protected]) or online at https://kaskelalaw.com/cases/xtant-medical-holdings-inc/ , for additional information about this investigation and their legal rights and options.
Kaskela Law LLC exclusively represents investors in securities fraud, corporate governance, and merger & acquisition litigation. For additional information about Kaskela Law LLC please visit www.kaskelalaw.com. This notice may constitute attorney advertising in certain jurisdictions.
CONTACT:
KASKELA LAW LLC
D. Seamus Kaskela, Esq.
Adrienne Bell, Esq.
18 Campus Blvd., Suite 100
Newtown Square, PA 19073
(888) 715 - 1740
(484) 229 - 0750
www.kaskelalaw.com
SOURCE: Kaskela Law LLC